Aadi Bioscience (FRA:3350) Gross Margin % : 87.82% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Aadi Bioscience's Gross Profit for the three months ended in Mar. 2024 was €4.33 Mil. Aadi Bioscience's Revenue for the three months ended in Mar. 2024 was €4.93 Mil. Therefore, Aadi Bioscience's Gross Margin % for the quarter that ended in Mar. 2024 was 87.82%.

The historical rank and industry rank for Aadi Bioscience's Gross Margin % or its related term are showing as below:

FRA:3350' s Gross Margin % Range Over the Past 10 Years
Min: 87.7 Med: 89.85 Max: 91.23
Current: 87.7

During the past 4 years, the highest Gross Margin % of Aadi Bioscience was 91.23%. The lowest was 87.70%. And the median was 89.85%.

FRA:3350's Gross Margin % is ranked better than
82.27% of 750 companies
in the Biotechnology industry
Industry Median: 60.91 vs FRA:3350: 87.70

Aadi Bioscience had a gross margin of 87.82% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Aadi Bioscience was 0.00% per year.

Aadi Bioscience Gross Margin % Historical Data

The historical data trend for Aadi Bioscience's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience Gross Margin % Chart

Aadi Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Gross Margin %

91.23

88.47

Aadi Bioscience Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross Margin %	Get a 7-Day Free Trial										90.99	89.43	88.29	85.35	87.82

Competitive Comparison of Aadi Bioscience's Gross Margin %

For the Biotechnology subindustry, Aadi Bioscience's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aadi Bioscience's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aadi Bioscience's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Aadi Bioscience's Gross Margin % falls into.

Aadi Bioscience Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Aadi Bioscience's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	19.8	/	22.333
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(22.333 - 2.576)	/	22.333
	=	88.47 %

Aadi Bioscience's Gross Margin for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )	=	Gross Profit (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	4.3	/	4.925
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(4.925 - 0.6)	/	4.925
	=	87.82 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Aadi Bioscience (FRA:3350) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Aadi Bioscience had a gross margin of 87.82% for the quarter that ended in Mar. 2024 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Aadi Bioscience Gross Margin % Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aadi Bioscience (FRA:3350) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

AADI:USA 3350:Germany

Address

17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272

Website

https://www.aadibio.com

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines